Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CardioComm Solutions Inc EKGGF


Primary Symbol: V.EKG

CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and... see more

Recent & Breaking News (TSXV:EKG)

CardioComm Solutions Prepares New FDA Applications for Direct-to-Consumer and Physician Use Cardiac Arrhythmia Algorhythms

Newsfile March 5, 2019

IIROC Trading Resumption - EKG

Canada NewsWire February 25, 2019

Innovation Continues as the FDA Clears CardioComm Solutions' Novel ECG Smartphone App and Heartcheck(TM) Device for Direct to Consumer Sales

Newsfile February 25, 2019

IIROC Trading Halt - AXV and EKG

Canada NewsWire February 22, 2019

CardioComm Solutions Engages US Law Firm to Address Licensing and IP Opportunities

Newsfile February 21, 2019

CardioComm Solutions Now Offers a Smartphone Connected FDA Cleared 12 Lead ECG Belt Under a New Co-Marketing Agreement

Newsfile February 13, 2019

CardioComm Solutions' HeartCheck(TM) Device Enters Final FDA Review Phase

Newsfile January 29, 2019

CardioComm Solutions Completes Work on Arrhythmia Detection Algorithms with Artificial Intelligence-Based Learning

Newsfile January 10, 2019

CardioComm Solutions' HeartCheck CardiBeat FDA 510(k) Review Extended

Newsfile December 31, 2018

CardioComm Solutions Provides Financing Update

Newsfile December 27, 2018

Creo Wellness Selects CardioComm Solutions' ECG Monitoring Service for Integration with USA Patient Engagement Platform

Newsfile December 14, 2018

CardioComm Solutions to Issue Shares Under Online Marketing and Awareness Program

Newsfile December 13, 2018

CardioComm Solutions Secures MDSAP ISO Certification for the Manufacturing, Marketing and Sale of Consumer and Rx Medical Devices into the USA and Canada

Newsfile December 12, 2018

CardioComm Solutions Appoints New Chief Financial Officer

Newsfile December 4, 2018

CardioComm Solutions' HeartCheck(TM) CardiBeat and Smart Phone App Enter Final Stage of FDA 510(k) Review

Newsfile November 23, 2018

CardioComm Solutions Launches Online Marketing and Awareness Program

Newsfile November 8, 2018

CardioComm Solutions Launches 12-Lead ECG Smart Wearable Garment Monitoring Solution

Newsfile October 30, 2018

CardioComm Solutions to Receive Royalty Payments from Biotricity

Newsfile October 22, 2018

CardioComm Solutions Sets the Record Straight; The First Company to Receive Approval for ECG Product Sales Direct to Consumers

Newsfile September 27, 2018

CardioComm Solutions Announces Extension of Warrants

Newsfile September 8, 2018